Zomedica Corp.
corporate_fare Company Profile
Zomedica Corp. (OTC:ZOMDF) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 4 items for ZOMDF at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-04, rated 7/10. Across its 4 most recent items scored 7 or higher, the top rating is 9/10, with 2 rated 8 or above. Recent SEC coverage for ZOMDF spans PRE 14A, 10-K.
Recent high-impact activity:
- Zomedica Posts Record $9.9M Q3 Revenue, Cuts Net Loss 48%
- Zomedica Posts 35% Q1 Revenue Growth to $8.8M, Significantly Cuts Net Loss
- Zomedica Faces Shareholder Dissent on Executive Pay, Proposes By-Law Change to Facilitate Meetings Amid Low Engagement
- Zomedica Reports NYSE American Delisting and $55.8M Impairment Amid Widening Losses in 2025 Annual Report
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 15,145 shares in ZOMDF as of the October 30, 2026 settlement, a 88.1% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 21.9% of ZOMDF volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.